These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 14963133)

  • 1. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.
    Keelapang P; Sriburi R; Supasa S; Panyadee N; Songjaeng A; Jairungsri A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol; 2004 Mar; 78(5):2367-81. PubMed ID: 14963133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.
    Junjhon J; Lausumpao M; Supasa S; Noisakran S; Songjaeng A; Saraithong P; Chaichoun K; Utaipat U; Keelapang P; Kanjanahaluethai A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol; 2008 Nov; 82(21):10776-91. PubMed ID: 18715923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
    Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus.
    Elshuber S; Mandl CW
    J Virol; 2005 Sep; 79(18):11813-23. PubMed ID: 16140758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
    Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry.
    Hsieh SC; Wu YC; Zou G; Nerurkar VR; Shi PY; Wang WK
    J Biol Chem; 2014 Nov; 289(48):33149-60. PubMed ID: 25326389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing dengue virus maturation using a stable furin over-expressing cell line.
    Mukherjee S; Sirohi D; Dowd KA; Chen Z; Diamond MS; Kuhn RJ; Pierson TC
    Virology; 2016 Oct; 497():33-40. PubMed ID: 27420797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
    Heiss BL; Maximova OA; Pletnev AG
    J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity.
    Hour MJ; Chen Y; Lin CS; Baltina LA; Kan JY; Tsai YT; Kiu YT; Lai HC; Baltina LA; Petrova SF; Lin CW
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions.
    Zheng A; Umashankar M; Kielian M
    PLoS Pathog; 2010 Oct; 6(10):e1001157. PubMed ID: 20975939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
    Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
    Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced production of infectious particles by adaptive modulation of C-prM processing and C-C interaction during propagation of dengue pseudoinfectious virus in stable CprME-expressing cells.
    Sangiambut S; Pethrak C; Anupap C; Ninnabkaew P; Kongsanthia C; Promphet N; Chaiyaloom S; Songjaeng A; Avirutnan P; Puttikhunt C; Kasinrerk W; Sittisombut N; Malasit P
    J Gen Virol; 2020 Jan; 101(1):59-72. PubMed ID: 31682220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin escape mutants of dengue virus map to prM and NS2B and reveal viral plasticity during maturation.
    Peng M; Swarbrick CMD; Chan KW; Luo D; Zhang W; Lai X; Li G; Vasudevan SG
    Antiviral Res; 2018 Jun; 154():87-96. PubMed ID: 29665375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of the dengue virus type 2 proteins prM and C-prM.
    Murray JM; Aaskov JG; Wright PJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():175-82. PubMed ID: 8429301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
    Pletnev AG; Bray M; Lai CJ
    J Virol; 1993 Aug; 67(8):4956-63. PubMed ID: 8331735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Cleavage of Japanese Encephalitis Virus prM Protein Promotes Viral Replication but Attenuates Virulence.
    Xiong J; Yan M; Zhu S; Zheng B; Wei N; Yang L; Si Y; Cao S; Ye J
    Microbiol Spectr; 2022 Jun; 10(3):e0141722. PubMed ID: 35695552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
    Pletnev AG; Bray M; Huggins J; Lai CJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.